arrow
返回
K

Kohei Shitara

national cancer center - japan

79H指数
1.1K论文数
3.5W被引数
收录论文 275
发表时间
Author's Reply: Neutrophil-Macrophage Interactions in Gastric Cancer作者回复:中性粒细胞-巨噬细胞相互作用在胃癌中的作用
err2026-08-25
err0
errOAAI
errKeita H. Nagaoka; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Takuya Nakatsuru; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Sai M. Pulukuri; Yuko Ishii; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
err分享
err收藏
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialPALADIN试验:一项关于短程放疗联合化疗作为不可切除局部晚期食管鳞状细胞癌诱导治疗的帕博利珠单抗的II期研究
err2026-06-01
err0
PREAI
errOkemoto, D.; Kotani, D.; Nakamura, M.; Sato, K.; Kubo, Y.; Kadota, T.; Mishima, S.; Sakashita, S.; Hashimoto, T.; Bando, H.; Wakabayashi, M.; Rabinowitz, M.; Liu, M. C.; Jurdi, A.; Yamaguchi, T.; Nishikawa, H.; Shitara, K.; Yano, T.; Kojima, T.; Fujita, Takeo
err分享
err收藏
Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studiesFGFR2b蛋白过表达在晚期胃癌和胃食管结合部癌症中的全球流行率:两项bemarituzumab III期研究的合并分析
err2026-05-26
err0
errOAAI
errS.B. Maron; R.-H. Xu; Z.A. Wainberg; S.Y. Rha; Y. Zhang; F. Pietrantonio; S.C.S. Oliveira; Y. Li; M.-H. Chen; K. Korphaisarn; E. Elimova; C.A. Calderon; F.V. Herpe; W.P. Yong; T.M. Dos Santos; M. Tan; K. Isse; R.E. Yanes; K. Shitara
err分享
err收藏
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric CancercDC1-NK/T-恶性细胞回路在PD-1阻断下驱动胃癌的免疫原性重塑
err2026-05-21
err0
errOAAI
errTakuya Nakatsuru; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Keita H. Nagaoka; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Yuko Ishii; Sai M. Pulukuri; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
err分享
err收藏
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-Immunotherapy中性粒细胞-巨噬细胞相互作用塑造化疗免疫治疗期间胃癌中炎症巨噬细胞的重塑
err2026-05-21
err0
errOAAI
errKeita H. Nagaoka; Hiroki Yamashita; Chiaki Mashima; Guoqiang Zhang; Hitoshi Saito; Tatsunori Minamide; Takuya Nakatsuru; Ryo Kamata; Shunsuke A. Sakai; Gaku Yamamoto; Tomoko Y. Morita; Kazuki Nakai; Yumi Hakozaki; Kumi Kinoshita; Yui Takahashi; Izuma Nakayama; Akihito Kawazoe; Sai M. Pulukuri; Yuko Ishii; Hiroshi Haeno; Yukie Kashima; Kohei Shitara; Tomonori Yano; Takeshi Saito; Akihiro Ohashi
err分享
err收藏
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons胃食管腺癌围手术期治疗的转变:成就、挫折与未来展望
err2026-05-15
err0
PREAI
errHongcheng Zhu; Florian Lordick; Yelena Y. Janjigian; Sun Young Rha; Magnus Nilsson; Kohei Shitara; Richard Owen; Zhen Zhang; Elizabeth C. Smyth
err分享
err收藏
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trialsZolbetuximab联合化疗在日本Claudin 18.2阳性胃癌或胃食管结合部腺癌患者中的应用:SPOTLIGHT和GLOW III期试验的合并亚组分析
err2026-05-07
err0
errOAAI
errKensei Yamaguchi; Hirokazu Shoji; Hisateru Yasui; Eiji Oki; Daisuke Sakai; Tetsuya Hamaguchi; Akihito Tsuji; Takashi Oshima; Masahiro Tsuda; Keiko Minashi; Jianning Yang; Abraham Guerrero; Yoko Ueno; Maria Matsangou; Georgia Gourgioti; Yuka Nakanishi; Satomi Furuki; Kana Kuwamoto; Shunsuke Yamada; Kohei Shitara
err分享
err收藏
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial一线zolbetuximab联合mFOLFOX6和nivolumab治疗不可切除的CLDN18.2阳性胃或胃食管结合部腺癌:一项Ⅱ期临床试验
err2026-03-16
err0
errOAAI
errKohei Shitara; Hirokazu Shoji; Nicola Fazio; Sara Lonardi; Keun-Wook Lee; Li-Yuan Bai; Kensei Yamaguchi; Jean-Philippe Metges; Gianluca Masi; Denis Smith; Tae-Yong Kim; Maria Matsangou; Archita Shrivastava; Miaomai Zhou; Jason Hill; Abraham Guerrero; Xuewei Wang; Aziz Zaanan; Samuel J. Klempner
err分享
err收藏
Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma☆KEYNOTE-585研究中生存的替代终点:新辅助/辅助性帕博利珠单抗联合化疗对比安慰剂联合化疗治疗胃或胃食管结合部腺癌☆
err2026-02-26
err0
errOAAI
errK. Shitara; Y.-J. Bang; L.S. Wyrwicz; S.Y. Rha; T. Oshima; F. Pietrantonio; Y.-K. Park; S. Lonardi; P. Yañez; C.-J. Yen; J.-P. Metges; M. Garrido; M. Moehler; S. Pelles-Avraham; W.P. Yong; A. Spallanzani; E. Jensen; R. Krishnan; C.-S. Shih; S.-E. Al-Batran
err分享
err收藏
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649纳武利尤单抗联合化疗作为晚期胃、胃食管结合部及食管腺癌的一线治疗方案:CheckMate 649研究的5年随访结果
err2026-02-11
err0
PREAI
errY.Y. Janjigian; K. Shitara; J.A. Ajani; L. Shen; M. Garrido; C. Gallardo; L. Wyrwicz; K. Yamaguchi; J.M. Cleary; E. Elimova; R. Bruges; M. Karamouzis; T. Skoczylas; A. Bragagnoli; T. Liu; M. Tehfe; T. Zander; R. Kowalyszyn; R. Pazo-Cid; M. Schenker
err分享
err收藏
Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies
err2026-01-08
err0
errOAAI
errK. Shitara; E. Smyth; F. Lordick; R. Pophale; C. Matney; M. Matsangou; G. Gourgioti; M. Oh; R. Ranganath; S.J. Klempner
err分享
err收藏
Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies根据剂量对曲妥珠单抗德鲁替康的安全性特征进行表征:一项跨越DESTINY研究的合并分析
err2026-01-01
err0
PREAI
errPark, Yeon Hee; Cortes, Javier; Modi, Shanu; Hurvitz, Sara A.; Bianchini, Giampaolo; Iwata, Hiroji; Shitara, Kohei; Siena, Salvatore; Goto, Yasushi; Ku, Geoffrey Y.; Powell, Charles A.; Swain, Sandra M.; Arunachalam, Meena; Janek, Martin; Cheng, Yingkai; Chu, Changan; Verma, Purnima; Kuptsova-Clarkson, Nataliya; Mathias, Elton; Goodman, Erin; Rugo, Hope S.
err分享
err收藏
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies建模并处理靶向/脱靶毒性问题:针对claudin 18.2的靶向免疫疗法
err2025-11-01
err0
errOAAI
errElizabeth J. Carstens; Kazuki Takahashi; Naoya Sakamoto; Martina De Vizio; Micaela Morgado; Shahryar Khoshtinat Nikkhoi; Abhishek Mangipudi; Canh Hiep Nguyen; Tate Weltzin; Izuma Nakayama; Qiang Lv; Jue Zeng; Cui Nie; Changjing Deng; Xiaoxiao Wang; Lile Liu; Samuel J. Klempner; Anusuya Ramasubramanian; Jonathan A. Nowak; Andrew J. Aguirre; Kohei Shitara; Eric L. Smith
err分享
err收藏
err分享
err收藏
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancersBeamion BCGC-1:zongertinib治疗晚期HER2阳性乳腺癌或胃肠癌的Ib/II期临床试验
err2025-10-17
err0
errOAAI
errSara Hurvitz; Matteo Simonelli; Ramón Yarza; David Berz; Shigehisa Kitano; Gianluca Del Conte; Daniel Acosta Eyzaguirre; Bernard Gaston Doger de Speville Uribe; Daniela Maier; Damijan Erzen; Sila Aykut Yazgili; Giuseppe Curigliano; Ting Deng; Min Yan; Qingyuan Zhang; Xian Wang; Izuma Nakayama; Kohei Shitara
err分享
err收藏
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study随着奥沙利铂为基础的化疗联合靶向药物,转移性结直肠癌的生存率随时间推移呈逐年改善:一项ARCAD数据库研究
err2025-10-02
err0
errOAAI
errKazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
err分享
err收藏
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancerCLDN18.2阳性胃癌患者接受含zolbetuximab化疗期间早期胃炎的特征分析
err2025-09-30
err0
errOAAI
errK. Yamamoto; Y. Owaki; I. Nakayama; N. Sakamoto; M. Ishizaka; T. Kadota; D. Okemoto; Y. Matsubara; Y. Miyashita; A. Kobayashi; U. Okazaki; K. Seguchi; T. Hosokai; T. Ogura; S. Mishima; D. Kotani; A. Kawazoe; T. Hashimoto; Y. Kuboki; H. Bando; T. Kojima; T. Yoshino; T. Kuwata; G. Ishii; T. Yano; K. Shitara
err分享
err收藏